Literature DB >> 24118222

Osteonecrosis of the jaw from bone anti-resorptives: impact of skeletal site-dependent mesenchymal stem cells.

So Akintoye1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24118222      PMCID： PMC3946063          DOI： 10.1111/odi.12181

Source DB:  PubMed          Journal:  Oral Dis        ISSN： 1354-523X            Impact factor:   3.511


× No keyword cloud information.
  17 in total

1.  A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws.

Authors:  Filippo Moretti; Gian Andrea Pelliccioni; Lucio Montebugnoli; Claudio Marchetti
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-10-14

2.  Risks for jaw osteonecrosis drastically increases after 2 years of bisphosphonate therapy.

Authors:  Sunday O Akintoye; Elliot V Hersh
Journal:  J Evid Based Dent Pract       Date:  2012-06       Impact factor: 5.267

3.  Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.

Authors:  Vittorio Fusco; Claudia Galassi; Alfredo Berruti; Libero Ciuffreda; Cinzia Ortega; Giovannino Ciccone; Alberto Angeli; Oscar Bertetto
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

4.  Hematopoietic stem cells and bisphosphonate-related osteonecrosis of the jaw.

Authors:  S Elad; Y Zadik; N Yarom; R Or; M Y Shapira
Journal:  Oral Dis       Date:  2012-12-25       Impact factor: 3.511

Review 5.  Molecular mechanisms of action of bisphosphonates: current status.

Authors:  Anke J Roelofs; Keith Thompson; Sharon Gordon; Michael J Rogers
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

6.  Osteogenic potential of mandibular vs. long-bone marrow stromal cells.

Authors:  T L Aghaloo; T Chaichanasakul; O Bezouglaia; B Kang; R Franco; S M Dry; E Atti; S Tetradis
Journal:  J Dent Res       Date:  2010-09-01       Impact factor: 6.116

7.  Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw.

Authors:  Luigi Cella; Aldo Oppici; Mariacristina Arbasi; Mauro Moretto; Massimo Piepoli; Daniele Vallisa; Adriano Zangrandi; Camilla Di Nunzio; Luigi Cavanna
Journal:  Head Face Med       Date:  2011-08-17       Impact factor: 2.151

8.  Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2.

Authors:  Shozo Nishida; Masanobu Tsubaki; Mayumi Hoshino; Ayumi Namimatsu; Hiromi Uji; Shohei Yoshioka; Yoshihiro Tanimori; Masashi Yanae; Masahiro Iwaki; Kiyohiro Irimajiri
Journal:  Biochem Biophys Res Commun       Date:  2005-03-04       Impact factor: 3.575

9.  Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management.

Authors:  Lucio Montebugnoli; Laura Felicetti; Davide Bartolomeo Gissi; Angelo Pizzigallo; Gian Andrea Pelliccioni; Claudio Marchetti
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2007-05-07

10.  Allogeneic mesenchymal stem cell therapy for bisphosphonate-related jaw osteonecrosis in Swine.

Authors:  Yunsheng Li; Junji Xu; Lisha Mao; Yi Liu; Runtao Gao; Zongmei Zheng; Wanjun Chen; Anh Le; Songtao Shi; Songlin Wang
Journal:  Stem Cells Dev       Date:  2013-04-06       Impact factor: 3.272
View more
  2 in total

1.  Are drug-related dental management cautions in Lexicomp Online for Dentistry evidence-based? A systematic review of the literature.

Authors:  Ayesha Qadeer; Temitope T Omolehinwa; Mel Mupparapu; Sunday O Akintoye
Journal:  Quintessence Int       Date:  2019       Impact factor: 1.677

2.  The bone regenerative capacity of canine mesenchymal stem cells is regulated by site-specific multilineage differentiation.

Authors:  Juan Bugueño; Weihua Li; Pinky Salat; Ling Qin; Sunday O Akintoye
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.